AAAAAA

   
Results: 1-15 |
Results: 15
RELATIONSHIP BETWEEN PLASMA VISCOSITY AND THE SEVERITY OF CORONARY HEART-DISEASE
Authors: JUNKER R HEINRICH J ULBRICH H SCHULTE H SCHONFELD R KOHLER E ASSMANN G
Citation: R. Junker et al., RELATIONSHIP BETWEEN PLASMA VISCOSITY AND THE SEVERITY OF CORONARY HEART-DISEASE, Arteriosclerosis, thrombosis, and vascular biology, 18(6), 1998, pp. 870-875
PLASMINOGEN-ACTIVATOR INHIBITOR-1 4G 5G-POLYMORPHISM AND FACTOR-V Q506 MUTATION ARE NOT ASSOCIATED WITH MYOCARDIAL-INFARCTION IN YOUNG MEN/
Authors: JUNKER R HEINRICH J SCHULTE H TATARU M KOHLER E SCHONFELD R NOWAKGOTTL U ASSMANN G
Citation: R. Junker et al., PLASMINOGEN-ACTIVATOR INHIBITOR-1 4G 5G-POLYMORPHISM AND FACTOR-V Q506 MUTATION ARE NOT ASSOCIATED WITH MYOCARDIAL-INFARCTION IN YOUNG MEN/, Blood coagulation & fibrinolysis, 9(7), 1998, pp. 597-602
PLASMINOGEN-ACTIVATOR INHIBITOR-1 4G 4G-GENOTYPE IS ASSOCIATED WITH CEREBRAL SINUS THROMBOSIS IN FACTOR-V-LEIDEN CARRIERS/
Authors: JUNKER R NABAVI DG WOLFF E LUDEMANN P NOWAKGOTTL U KASE M BAUMER R RINGELSTEIN EB ASSMANN G
Citation: R. Junker et al., PLASMINOGEN-ACTIVATOR INHIBITOR-1 4G 4G-GENOTYPE IS ASSOCIATED WITH CEREBRAL SINUS THROMBOSIS IN FACTOR-V-LEIDEN CARRIERS/, Thrombosis and haemostasis, 80(4), 1998, pp. 706-707
PREVALENCE OF FACTOR-V-LEIDEN MUTATION IN YOUNG-ADULTS WITH CEREBRAL-ISCHEMIA - A CASE-CONTROL STUDY ON 225 PATIENTS
Authors: NABAVI DG JUNKER R WOLFF E LUDEMANN P DOHERTY C EVERS S DROSTE DW KESSLER C ASSMANN G RINGELSTEIN FB
Citation: Dg. Nabavi et al., PREVALENCE OF FACTOR-V-LEIDEN MUTATION IN YOUNG-ADULTS WITH CEREBRAL-ISCHEMIA - A CASE-CONTROL STUDY ON 225 PATIENTS, Journal of neurology, 245(10), 1998, pp. 653-658
HEMOSTASIS IN NORMOTENSIVE AND HYPERTENSIVE MEN - RESULTS OF THE PROCAM STUDY
Authors: JUNKER R HEINRICH J SCHULTE H ERREN M ASSMANN G
Citation: R. Junker et al., HEMOSTASIS IN NORMOTENSIVE AND HYPERTENSIVE MEN - RESULTS OF THE PROCAM STUDY, Journal of hypertension, 16(7), 1998, pp. 917-923
FACTOR-V-LEIDEN MUTATION IS A RISK FACTOR FOR CEREBRAL VENOUS THROMBOSIS - A CASE-CONTROL STUDY OF 55 PATIENTS
Authors: LUDEMANN P NABAVI DG JUNKER R WOLFF E PAPKE K BUCHNER H ASSMANN G RINGELSTEIN EB
Citation: P. Ludemann et al., FACTOR-V-LEIDEN MUTATION IS A RISK FACTOR FOR CEREBRAL VENOUS THROMBOSIS - A CASE-CONTROL STUDY OF 55 PATIENTS, Stroke, 29(12), 1998, pp. 2507-2510
CLINICAL-APPLICATION OF ULTRASENSITIVE PROSTATE-SPECIFIC ANTIGEN ASSAYS - RESPONSE
Authors: JUNKER R BRANDT B SEMJONOW A ASSMANN G
Citation: R. Junker et al., CLINICAL-APPLICATION OF ULTRASENSITIVE PROSTATE-SPECIFIC ANTIGEN ASSAYS - RESPONSE, Journal of the National Cancer Institute, 89(14), 1997, pp. 1078-1078
COAGULATION-FACTOR-VII AND THE RISK OF CORONARY HEART-DISEASE IN HEALTHY-MEN
Authors: JUNKER R HEINRICH J SCHULTE H VANDELOO J ASSMANN G
Citation: R. Junker et al., COAGULATION-FACTOR-VII AND THE RISK OF CORONARY HEART-DISEASE IN HEALTHY-MEN, Arteriosclerosis, thrombosis, and vascular biology, 17(8), 1997, pp. 1539-1544
NO APPARENT RESTRICTION ON MEASURING FVIIA IN FROZEN PLASMA
Authors: JUNKER R KASE M ERREN M ASSMANN G
Citation: R. Junker et al., NO APPARENT RESTRICTION ON MEASURING FVIIA IN FROZEN PLASMA, Thrombosis and haemostasis, 78(3), 1997, pp. 1162-1163
THE IMPORTANCE OF LP(A), LP AI, APO AI, APO AII, CONVENTIONAL RISK-FACTORS ON THE SEVERITY OF CORONARY-ARTERY DISEASE (CAD)
Authors: TATARU MC JUNKER R SCHULTE H VONECKARDSTEIN A SCHONFELD R ASSMANN G KOHLER E
Citation: Mc. Tataru et al., THE IMPORTANCE OF LP(A), LP AI, APO AI, APO AII, CONVENTIONAL RISK-FACTORS ON THE SEVERITY OF CORONARY-ARTERY DISEASE (CAD), Atherosclerosis, 134(1-2), 1997, pp. 21-21
D-DIMERS AND FIBRINOGEN IN PATIENTS WITH LEFT VENTRICLE-DYSFUNCTION AFTER MYOCARDIAL-INFARCTION AND IN GENERALIZED ATHEROSCLEROSIS
Authors: TATARU MC JUNKER R SCHULTE H VONECKARDSTEIN A SCHONFELD R ASSMANN G KOHLER E
Citation: Mc. Tataru et al., D-DIMERS AND FIBRINOGEN IN PATIENTS WITH LEFT VENTRICLE-DYSFUNCTION AFTER MYOCARDIAL-INFARCTION AND IN GENERALIZED ATHEROSCLEROSIS, Atherosclerosis, 134(1-2), 1997, pp. 195-196
THE ROLE OF CRP (C-REACTIVE-PROTEIN) IN MANIFEST AND SILENT ATHEROSCLEROSIS
Authors: TATARU MC SCHONFELD R SCHULTE H JUNKER R VONECKARDSTEIN A ASSMANN G KOHLER E
Citation: Mc. Tataru et al., THE ROLE OF CRP (C-REACTIVE-PROTEIN) IN MANIFEST AND SILENT ATHEROSCLEROSIS, Atherosclerosis, 134(1-2), 1997, pp. 262-263
COMPARISON OF PROSTATE-SPECIFIC ANTIGEN (PSA) MEASURED BY 4 COMBINATIONS OF FREE PSA AND TOTAL PSA ASSAYS
Authors: JUNKER R BRANDT B ZECHEL C ASSMANN G
Citation: R. Junker et al., COMPARISON OF PROSTATE-SPECIFIC ANTIGEN (PSA) MEASURED BY 4 COMBINATIONS OF FREE PSA AND TOTAL PSA ASSAYS, Clinical chemistry, 43(9), 1997, pp. 1588-1594
MEASUREMENT OF PROSTATE-SPECIFIC ANTIGEN - NO ADVANTAGE TO ULTRASENSITIVE ASSAYS
Authors: JUNKER R BRANDT B SEMJONOW A ASSMANN G
Citation: R. Junker et al., MEASUREMENT OF PROSTATE-SPECIFIC ANTIGEN - NO ADVANTAGE TO ULTRASENSITIVE ASSAYS, Journal of the National Cancer Institute, 88(21), 1996, pp. 1594-1595
ISOLATION OF PROSTATE-DERIVED SINGLE CELLS AND CELL CLUSTERS FROM HUMAN PERIPHERAL-BLOOD
Authors: BRANDT B JUNKER R GRIWATZ C HEIDL S BRINKMANN O SEMJONOW A ASSMANN G ZANKER KS
Citation: B. Brandt et al., ISOLATION OF PROSTATE-DERIVED SINGLE CELLS AND CELL CLUSTERS FROM HUMAN PERIPHERAL-BLOOD, Cancer research, 56(20), 1996, pp. 4556-4561
Risultati: 1-15 |